Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of New Mexico
ClinicalTrials.gov Identifier:
NCT00488605
First received: June 14, 2007
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)